NPI registry status
Active
2026 NPPES data Allergy & Immunology (Internal Medicine) Physician NPI 1659786440 MD-PHD
Verify on CMS → Robert Tamayev, MD-PHD
Allergy & Immunology (Internal Medicine) Physician in Rego Park, New York.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 517 in Allergy & Immunology (Internal Medicine) Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
712
Medicare Part D claims · 138 beneficiaries · Allergy & Immunology (Internal Medicine) Physician avg: 798
MIPS score
76.5/100
▼ 7 pts below national avg 83.1 · Above neutral
Industry payments
$95.4K
297 payments · CMS Open Payments (Sunshine Act)
Compiled from official public sources by the PlainDoctor editorial team.
What the federal data shows
Robert Tamayev, MD-PHD reported a CMS MIPS final score of 76.5/100 - below the 83.1 national average - and filed 712 Medicare Part D claims in 2023.
- 76.5/100
- MIPS score · -7 vs avg
- 712
- Part D claims, 2023
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Robert Tamayev, MD-PHD's MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
77 21st percentile higher than 21% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Robert Tamayev, MD-PHD sits
This provider among allergy & immunology (internal medicine) physician peers
Across the 130 allergy & immunology (internal medicine) physician providers who report both Medicare Part D prescribing and a MIPS quality score, Robert Tamayev, MD-PHD writes more Part D claims than 66% of them and scores higher on MIPS quality than 26% - placing this provider in the high-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one allergy & immunology (internal medicine) physician peer from a representative sample of 60; the gold marker is Robert Tamayev, MD-PHD. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Robert Tamayev, MD-PHD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Robert Tamayev, MD-PHD?
Below national averagePrimary specialty
Allergy & Immunology (Internal Medicine) Physician
Medicare Part D claims
712 11% vs specialty avg
MIPS final score
76.5/100 6.6 pts vs avg
Specialty distribution in New York
How Allergy & Immunology (Internal Medicine) Physician compares to other specialties among New York providers
Medicare quality performance, MIPS
Robert Tamayev, MD-PHD's 2023 MIPS final score plotted against the Allergy & Immunology (Internal Medicine) Physician national average
- MIPS Final Score
- 76.5/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Allergy & Immunology (Internal Medicine) Physician) - 76.5/100 vs national avg 83.1
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Robert Tamayev, MD-PHD appears in the CMS NPPES registry as an Allergy & Immunology (Internal Medicine) Physician provider holding MD-PHD credentials at 9876 QUEENS BLVD # 1JK, Rego Park, NY, 11374, with a listed phone of (347) 336-5972. NPI 1659786440 was issued on 06/30/2014.
Medicare Part D records for calendar year 2023 show 712 prescription claims written by this provider, covering 138 Medicare beneficiaries and totaling roughly $344K in drug spend. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 76.5/100 for the 2023 performance year (Quality 64, Cost 57.7), compared with the national average of 83.1.
Allergy & Immunology (Internal Medicine) Physician is a narrow specialty nationwide, with 517 enrolled providers across 47 states and an average of 798 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1659786440 |
|---|---|
| Specialty | Allergy & Immunology (Internal Medicine) Physician |
| Credentials | MD-PHD |
| Gender | Male |
| NPI Issued | 06/30/2014 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
76.5288
Final Score
Avg: 83.1
64.0296
Quality
57.7329
Cost
100
Promoting Interoperability
Reporting: Group practice
Hospital and facility affiliations
Facilities where Robert Tamayev, MD-PHD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
City Medical OF Upper East Side PLLC
Astoria, NY
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Robert Tamayev, MD-PHD. Source: openpaymentsdata.cms.gov.
Total received
$95.4K
Largest payer
GENZYME CORPORATION
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - New York NYSBPMC 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 - they are NOT specific to Robert Tamayev, MD-PHD. To verify Robert Tamayev, MD-PHD's current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases
NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
712
Total Claims
$344K
Total Drug Cost
138
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 822
- Total Day Supply
- 21,892
- Generic Drug Cost
- $19K
- Antibiotic Claims
- 49
Patient Demographics
- Average Patient Age
- 71.9 years
- Avg HCC Risk Score
- 1.47
- Gender Split
- 67% female / 33% male
- Age Distribution
- <65: 21, 65-74: 65, 75-84: 36, 85+: 16
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Robert Tamayev, MD-PHD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Azelastine Hcl
Azelastine Hcl
113 claims
- Fluticasone Propio…
Fluticasone Propionate
73 claims
- Montelukast Sodium
Montelukast Sodium
65 claims
- Triamcinolone Acet… 44
Triamcinolone Acetonide
44 claims
- Xolair 27
Xolair
27 claims
- Prednisone 25
Prednisone
25 claims
- Dupixent Syringe 24
Dupixent Syringe
24 claims
- Trelegy Ellipta 23
Trelegy Ellipta
23 claims
| Drug | Claims |
|---|---|
| Azelastine Hcl | 113 |
| Fluticasone Propionate | 73 |
| Montelukast Sodium | 65 |
| Triamcinolone Acetonide | 44 |
| Xolair Omalizumab | 27 |
| Prednisone | 25 |
| Dupixent Syringe Dupilumab | 24 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 23 |
| Famotidine | 20 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 17 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
More Allergy & Immunology (Internal Medicine) Physician in NY →
All providers in New York →
Compare specialties →
Allergy & Immunology (Internal Medicine) Physician Overview
How Robert Tamayev, MD-PHD fits within the Allergy & Immunology (Internal Medicine) Physician landscape nationally.
517
Allergy & Immunology (Internal Medicine) Physician Providers in US
47
States with Allergy & Immunology (Internal Medicine) Physician
798
Avg Claims per Provider
Robert Tamayev, MD-PHD's 712 claims are below the specialty average of 798.
Nearby Allergy & Immunology (Internal Medicine) Physician Providers in New York
Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as Tamayev.
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the New York medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Allergy & Immunology (Internal Medicine) Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
How to Find a Doctor
Step-by-step guide to choosing a provider
Verify Credentials
Check NPI, board certification & license status
Medical Specialties Explained
Who treats what and how specialties differ
Understanding Medicare Claims Data
What prescribing data reveals about a provider
In-Network vs Out-of-Network
How insurance networks affect your costs
Telehealth Guide
Virtual care options and coverage in 2026
Explore New York
Frequently Asked Questions
What is Robert Tamayev, MD-PHD's specialty? ▼
Robert Tamayev, MD-PHD specializes in Allergy & Immunology (Internal Medicine) Physician and practices in Rego Park, New York. Credentials: MD-PHD.
How much does Robert Tamayev, MD-PHD prescribe under Medicare Part D? ▼
In 2023, Robert Tamayev, MD-PHD wrote 712 Medicare Part D claims totaling $344K in drug costs for 138 beneficiaries.
What is Robert Tamayev, MD-PHD's Medicare quality score? ▼
Robert Tamayev, MD-PHD has a CMS MIPS Final Score of 76.5/100 (Quality: 64, Cost: 57.7). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Robert Tamayev, MD-PHD located? ▼
Robert Tamayev, MD-PHD is located at 9876 QUEENS BLVD # 1JK, Rego Park, NY, 11374. Phone: (347) 336-5972.
What is Robert Tamayev, MD-PHD's NPI number? ▼
Robert Tamayev, MD-PHD's National Provider Identifier (NPI) is 1659786440, issued on 06/30/2014.
How many Allergy & Immunology (Internal Medicine) Physician providers are there in the US? ▼
There are 517 Allergy & Immunology (Internal Medicine) Physician providers across 47 states in the US. The average Allergy & Immunology (Internal Medicine) Physician provider writes 798 Medicare Part D claims per year.
What drugs does Robert Tamayev, MD-PHD prescribe most often? ▼
Based on 2023 Medicare Part D data, Robert Tamayev, MD-PHD's most frequently prescribed drugs include Azelastine Hcl, Fluticasone Propionate, Montelukast Sodium. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Robert Tamayev, MD-PHD accept Medicare? ▼
Robert Tamayev, MD-PHD appears in CMS Medicare data with 712 Part D claims and 138 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Robert Tamayev, MD-PHD's credentials? ▼
Robert Tamayev, MD-PHD's NPI is 1659786440 with credentials MD-PHD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Compiled from official public sources by the PlainDoctor editorial team.
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.